Appointments at Sanofi, GSK, Eli Lilly and Watson Pharmaceuticals – People on the move
in-PharmaTechnologist presents its latest round-up of movements in the pharma sector including appointments at Sanofi, GSK, Eli Lilly and Watson Pharmaceuticals.
in-PharmaTechnologist presents its latest round-up of movements in the pharma sector including appointments at Sanofi, GSK, Eli Lilly and Watson Pharmaceuticals.
Training firm Clinical Research Site Training (CRST) has released the findings of a survey into the impact of increasingly complex clinical trials.
Gerresheimer has taken out a new loan to refinance four years ahead for schedule, citing the favourable financial climate as the key driver.
Amgen will buy a manufacturing facility in Ireland from US drug giant Pfizer, securing the site’s workforce.
The Japanese drug sector seems to have survived the earthquake and tsunami that struck the country largely unscathed, with early reports suggesting that most manufacturing sites have escaped damage.
Supply chain services firm Tracelink says that half of Catalent Pharma Solutions’ US manufacturing sites have been added to its network under the strategic partnership signed last summer.
GlobalCare, the ambulatory clinical trial specialist, has announced it intends to expand its operations into Latin America.
CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed.